why choose us

First received: September 06, 2022

Clinical Trial: Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Castration-resistant Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: Phase II Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

Brief Summary: This is an open-label, multi-site study of apalutamide with carotuximab in patients who have progressed on androgen receptor signaling inhibitor (ARSI) therapy.This study will begin with a safety assessment in the first 10 subjects (part 1: Safety Lead-in).If the combination is deemed safe, the trial will proceed to the Phase II stage.The purpose of this study is to compare progression free survival (PFS) between patients receiving apalutamide and apalutamide + carotuximab using Response Evaluation Criteria in…

Read more